<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02356692</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-38-MTF</org_study_id>
    <nct_id>NCT02356692</nct_id>
  </id_info>
  <brief_title>Clinical Comfort Evaluation of Two Marketed Spherical Contact Lenses</brief_title>
  <official_title>Clinical Comfort Evaluation of Two Marketed Spherical Contact Lenses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate the overall clinical comfort performance of&#xD;
      enfilcon A (test) lens and senofilcon A (control) lens over 15-minutes of lens wear.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was a non-dispensing, single-masked, randomized, contralateral study comparing Enfilcon&#xD;
      A (test) against Senofilcon A (control). Each subject was randomized to wear the test lens in&#xD;
      one eye and the control lens in the other eye.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort at Insertion</measure>
    <time_frame>Baseline</time_frame>
    <description>Participant's response for comfort at insertion. (Scale 0-10; 0=poor/intolerable, 10=comfortable/ cannot be felt) Obtained at baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort at Insertion</measure>
    <time_frame>15 minutes</time_frame>
    <description>Participant's response for comfort at 15 minutes. (Scale 0-10; 0=poor/intolerable, 10=comfortable/ cannot be felt) Obtained at 15 minutes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort Preference</measure>
    <time_frame>Baseline</time_frame>
    <description>Participant's response for comfort preference of enfilcon A (test) lens, senofilcon A(control) lens at insertion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort Preference</measure>
    <time_frame>15 minutes</time_frame>
    <description>Participant's response for comfort of enfilcon A (test) lens, senofilcon A (control) lens at 15 minutes wear.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>enfilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants randomized to wear the Enfilcon A (test) lens in one eye and Senofilcon A (control) lens in the other eye.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>senofilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>participants randomized to wear the Enfilcon A (test) lens in one eye and Senofilcon A (control) lens in the other eye.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>enfilcon A</intervention_name>
    <description>Test lens</description>
    <arm_group_label>enfilcon A</arm_group_label>
    <arm_group_label>senofilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A</intervention_name>
    <description>Control lens</description>
    <arm_group_label>enfilcon A</arm_group_label>
    <arm_group_label>senofilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Based on his/her knowledge, must be in good general health.&#xD;
&#xD;
          2. Be 18 to 38 years old.&#xD;
&#xD;
          3. Be able and willing to adhere to the instructions set forth in this protocol and&#xD;
             complete all specified evaluation.&#xD;
&#xD;
          4. Read, indicate understanding of, and sign Written Informed Consent.&#xD;
&#xD;
          5. Be existing or successfully adapted users of soft contact lenses, but not currently&#xD;
             wearing either of the study lenses (Avaira or Oasys) being evaluated in this trial.&#xD;
&#xD;
          6. Require a visual correction in both eyes.&#xD;
&#xD;
          7. Require a prescription between +8.00D and -12.00D and have less than or equal to 0.75D&#xD;
             of astigmatism in both eyes.&#xD;
&#xD;
          8. Achieve visual acuity of 20/25 or better in each eye with a spherical contact lens&#xD;
             prescription.&#xD;
&#xD;
          9. Have normal eyes with no evidence of abnormality or disease. For the purposes of this&#xD;
             study a normal eye is defined as one having:&#xD;
&#xD;
               -  No amblyopia.&#xD;
&#xD;
               -  No evidence of lid abnormality or infection (e.g. entropion, ectropion, chalazia,&#xD;
                  recurrent styes).&#xD;
&#xD;
               -  lamp findings Grade 2 or above: corneal edema, tarsal abnormalities, and&#xD;
                  conjunctival injection).&#xD;
&#xD;
               -  No other active ocular disease (e.g. glaucoma, history of recurrent corneal&#xD;
                  erosions, cornea [infiltrates], conjunctiva, lids, and intraocular infection or&#xD;
                  inflammation of an allergic, bacterial, or viral etiology).&#xD;
&#xD;
               -  No aphakia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. 0.75D or greater of refractive astigmatism in either eye.&#xD;
&#xD;
          2. Presbyopic or current monovision contact lens wear.&#xD;
&#xD;
          3. Cannot be currently wearing either lenses (Avaira or Oasys).&#xD;
&#xD;
          4. Presence of clinically significant (grade 2-4) anterior segment abnormalities;&#xD;
             inflammation such as iritis; or any infection of the eye, lids, or associated&#xD;
             structures.&#xD;
&#xD;
          5. Presence of ocular or systemic disease or need of medication which might interfere&#xD;
             with contact lens wear.&#xD;
&#xD;
          6. Slit lamp findings that would contraindicate contact lens wear such as:&#xD;
&#xD;
               -  Pathological dry eye or associated findings&#xD;
&#xD;
               -  Pterygium, pinguecula or corneal scars within the visual axis&#xD;
&#xD;
               -  Neovascularization &gt; 0.75 mm in from the limbus&#xD;
&#xD;
               -  Giant papillary conjunctivitis (GPC) worse than Grade 1&#xD;
&#xD;
               -  Anterior uveitis or iritis (past or present)&#xD;
&#xD;
               -  Seborrheic eczema, seborrheic conjunctivitis&#xD;
&#xD;
               -  History of corneal ulcer or fungal infections&#xD;
&#xD;
               -  Poor personal hygiene&#xD;
&#xD;
               -  A known history of corneal hypoesthesia (reduced corneal sensitivity)&#xD;
&#xD;
          7. Contact Lens best corrected Snellen visual acuities (VA) worse than 20/30.&#xD;
&#xD;
          8. Aphakia, Keratoconus or a highly irregular cornea.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Donald Siegel, OD</last_name>
    <role>Study Chair</role>
    <affiliation>Coopervision, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Schaeffer Eye Associates</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beaches Family Eyecare</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Todays Eyecare, LLC</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <zip>70503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>April 30, 2012</study_first_submitted>
  <study_first_submitted_qc>February 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2015</study_first_posted>
  <results_first_submitted>October 5, 2020</results_first_submitted>
  <results_first_submitted_qc>October 30, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 23, 2020</results_first_posted>
  <last_update_submitted>October 30, 2020</last_update_submitted>
  <last_update_submitted_qc>October 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Enfilcon A</title>
          <description>participants randomized to wear the (enfilcon A) test lens in one eye.&#xD;
Enfilcon A: contact lens</description>
        </group>
        <group group_id="P2">
          <title>Senofilcon A</title>
          <description>participants randomized to wear the senofilcon A contact lens (control) in the one eye.&#xD;
Senofilcon A: contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall Study Group</title>
          <description>participants randomized to wear the (enfilcon A) test lens in one eye and the senofilcon A (control) in the other eye.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comfort at Insertion</title>
        <description>Participant's response for comfort at insertion. (Scale 0-10; 0=poor/intolerable, 10=comfortable/ cannot be felt) Obtained at baseline.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Enfilcon A</title>
            <description>participants randomized to wear the (enfilcon A) test lens in one eye.&#xD;
enfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A</title>
            <description>participants randomized to wear the senofilcon A (control) lens in the one eye.&#xD;
senofilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort at Insertion</title>
          <description>Participant's response for comfort at insertion. (Scale 0-10; 0=poor/intolerable, 10=comfortable/ cannot be felt) Obtained at baseline.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.7" spread="1.6"/>
                    <measurement group_id="O2" value="8.5" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort at Insertion</title>
        <description>Participant's response for comfort at 15 minutes. (Scale 0-10; 0=poor/intolerable, 10=comfortable/ cannot be felt) Obtained at 15 minutes.</description>
        <time_frame>15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Enfilcon A</title>
            <description>participants randomized to wear the (enfilcon A) test lens in one eye.&#xD;
enfilcon A: contact lens</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A</title>
            <description>participants randomized to wear the senofilcon A control lens in one eye.&#xD;
senofilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort at Insertion</title>
          <description>Participant's response for comfort at 15 minutes. (Scale 0-10; 0=poor/intolerable, 10=comfortable/ cannot be felt) Obtained at 15 minutes.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Eyes</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.1" spread="1.8"/>
                    <measurement group_id="O2" value="8.7" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort Preference</title>
        <description>Participant's response for comfort preference of enfilcon A (test) lens, senofilcon A(control) lens at insertion.</description>
        <time_frame>Baseline</time_frame>
        <population>n=59, one participant would not choose a preference at the initial insertion as both lenses were the same to them.</population>
        <group_list>
          <group group_id="O1">
            <title>Overall Study Group</title>
            <description>participants randomized to wear the (enfilcon A) test lens in one eye and the senofilcon A (control) in the other eye.&#xD;
Enfilcon A: contact lens Senofilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort Preference</title>
          <description>Participant's response for comfort preference of enfilcon A (test) lens, senofilcon A(control) lens at insertion.</description>
          <population>n=59, one participant would not choose a preference at the initial insertion as both lenses were the same to them.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Prefer Enfilcon A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Prefer Senofilcon A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort Preference</title>
        <description>Participant's response for comfort of enfilcon A (test) lens, senofilcon A (control) lens at 15 minutes wear.</description>
        <time_frame>15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Overall Study Group</title>
            <description>participants randomized to wear the (enfilcon A) test lens in one eye and the senofilcon A (control) in the other eye.&#xD;
Enfilcon A: contact lens Senofilcon A: contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort Preference</title>
          <description>Participant's response for comfort of enfilcon A (test) lens, senofilcon A (control) lens at 15 minutes wear.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Preferred Enfilcon A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Preferred Senofilcon A</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From dispense up to 15 minutes for both study lenses.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Enfilcon A</title>
          <description>participants randomized to wear the test lens (enfilcon A) in one eye.&#xD;
Enfilcon A: contact lens</description>
        </group>
        <group group_id="E2">
          <title>Senofilcon A</title>
          <description>participants randomized to wear the control lens (senofilcon A) in the one eye.&#xD;
Senofilcon A: contact lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Recipient agress to maintain Confidential Information in strict confidence, not to disclose Confidential Information to any third parties and no to use Confidential Information for any purposes execpt for Business Purpose.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Donald Siegel, OD</name_or_title>
      <organization>CooperVision</organization>
      <phone>602 485 3414</phone>
      <email>dsiegel@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

